The earliest description of an incompatible hemolytic transfusion reaction dates to the experimental start of transfusion therapy in the mid-17th century. While treating a nobleman who had episodes of ...
A Japanese center found that hemolysis was significantly more common after TAVR with the Sapien 3 Ultra Resilia than with its predecessor device, despite the improvement on paravalvular leaks. Annular ...
Physical/chemical causes. These causes of hemolysis are most often secondary to improper handling of blood products. Reasons include inadvertent heating or freezing with subsequent thawing of the red ...
The phase 3 PEGASUS trial found that patients with paroxysmal nocturnal hemoglobinuria (PNH) may still experience anemia following recommended therapies, underscoring the need for further research. In ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results